Report Detail
Global Dermatophytosis Treatment Market Insights, Forecast to 2025
- RnM3447572 |
- 22 May, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Ringworm on the skin like athlete's foot (tinea pedis) and jock itch (tinea cruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks.
The global Dermatophytosis Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dermatophytosis Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Dermatophytosis Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dermatophytosis Treatment in these regions.
This research report categorizes the global Dermatophytosis Treatment market by top players/brands, region, type and end user. This report also studies the global Dermatophytosis Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Pfizer
Sanofi-Aventis
Merck
Enzon Pharmaceuticals
Bayer
Astellas Pharma
GSK
Abbott
Market size by Product
Rx
OTC
Market size by End User
Hospital
Clinic
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dermatophytosis Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dermatophytosis Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dermatophytosis Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dermatophytosis Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dermatophytosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dermatophytosis Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Dermatophytosis Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Dermatophytosis Treatment Market Size Growth Rate by Product
- 1.4.2 Rx
- 1.4.3 OTC
- 1.5 Market by End User
- 1.5.1 Global Dermatophytosis Treatment Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dermatophytosis Treatment Market Size
- 2.1.1 Global Dermatophytosis Treatment Revenue 2014-2025
- 2.1.2 Global Dermatophytosis Treatment Sales 2014-2025
- 2.2 Dermatophytosis Treatment Growth Rate by Regions
- 2.2.1 Global Dermatophytosis Treatment Sales by Regions
- 2.2.2 Global Dermatophytosis Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Dermatophytosis Treatment Sales by Manufacturers
- 3.1.1 Dermatophytosis Treatment Sales by Manufacturers
- 3.1.2 Dermatophytosis Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Dermatophytosis Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Dermatophytosis Treatment Revenue by Manufacturers
- 3.2.1 Dermatophytosis Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Dermatophytosis Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Dermatophytosis Treatment Price by Manufacturers
- 3.4 Dermatophytosis Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Dermatophytosis Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dermatophytosis Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Dermatophytosis Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Dermatophytosis Treatment Sales by Product
- 4.2 Global Dermatophytosis Treatment Revenue by Product
- 4.3 Dermatophytosis Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Dermatophytosis Treatment Breakdown Data by End User
6 North America
- 6.1 North America Dermatophytosis Treatment by Countries
- 6.1.1 North America Dermatophytosis Treatment Sales by Countries
- 6.1.2 North America Dermatophytosis Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Dermatophytosis Treatment by Product
- 6.3 North America Dermatophytosis Treatment by End User
7 Europe
- 7.1 Europe Dermatophytosis Treatment by Countries
- 7.1.1 Europe Dermatophytosis Treatment Sales by Countries
- 7.1.2 Europe Dermatophytosis Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Dermatophytosis Treatment by Product
- 7.3 Europe Dermatophytosis Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Dermatophytosis Treatment by Countries
- 8.1.1 Asia Pacific Dermatophytosis Treatment Sales by Countries
- 8.1.2 Asia Pacific Dermatophytosis Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Dermatophytosis Treatment by Product
- 8.3 Asia Pacific Dermatophytosis Treatment by End User
9 Central & South America
- 9.1 Central & South America Dermatophytosis Treatment by Countries
- 9.1.1 Central & South America Dermatophytosis Treatment Sales by Countries
- 9.1.2 Central & South America Dermatophytosis Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Dermatophytosis Treatment by Product
- 9.3 Central & South America Dermatophytosis Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Dermatophytosis Treatment by Countries
- 10.1.1 Middle East and Africa Dermatophytosis Treatment Sales by Countries
- 10.1.2 Middle East and Africa Dermatophytosis Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Dermatophytosis Treatment by Product
- 10.3 Middle East and Africa Dermatophytosis Treatment by End User
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Novartis Dermatophytosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Novartis Dermatophytosis Treatment Products Offered
- 11.1.5 Novartis Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Dermatophytosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Dermatophytosis Treatment Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Sanofi-Aventis
- 11.3.1 Sanofi-Aventis Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sanofi-Aventis Dermatophytosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sanofi-Aventis Dermatophytosis Treatment Products Offered
- 11.3.5 Sanofi-Aventis Recent Development
- 11.4 Merck
- 11.4.1 Merck Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Merck Dermatophytosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Merck Dermatophytosis Treatment Products Offered
- 11.4.5 Merck Recent Development
- 11.5 Enzon Pharmaceuticals
- 11.5.1 Enzon Pharmaceuticals Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Enzon Pharmaceuticals Dermatophytosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Enzon Pharmaceuticals Dermatophytosis Treatment Products Offered
- 11.5.5 Enzon Pharmaceuticals Recent Development
- 11.6 Bayer
- 11.6.1 Bayer Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Bayer Dermatophytosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Bayer Dermatophytosis Treatment Products Offered
- 11.6.5 Bayer Recent Development
- 11.7 Astellas Pharma
- 11.7.1 Astellas Pharma Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Astellas Pharma Dermatophytosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Astellas Pharma Dermatophytosis Treatment Products Offered
- 11.7.5 Astellas Pharma Recent Development
- 11.8 GSK
- 11.8.1 GSK Company Details
- 11.8.2 Company Business Overview
- 11.8.3 GSK Dermatophytosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 GSK Dermatophytosis Treatment Products Offered
- 11.8.5 GSK Recent Development
- 11.9 Abbott
- 11.9.1 Abbott Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Abbott Dermatophytosis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Abbott Dermatophytosis Treatment Products Offered
- 11.9.5 Abbott Recent Development
12 Future Forecast
- 12.1 Dermatophytosis Treatment Market Forecast by Regions
- 12.1.1 Global Dermatophytosis Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Dermatophytosis Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Dermatophytosis Treatment Market Forecast by Product
- 12.2.1 Global Dermatophytosis Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Dermatophytosis Treatment Revenue Forecast by Product 2019-2025
- 12.3 Dermatophytosis Treatment Market Forecast by End User
- 12.4 North America Dermatophytosis Treatment Forecast
- 12.5 Europe Dermatophytosis Treatment Forecast
- 12.6 Asia Pacific Dermatophytosis Treatment Forecast
- 12.7 Central & South America Dermatophytosis Treatment Forecast
- 12.8 Middle East and Africa Dermatophytosis Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dermatophytosis Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dermatophytosis Treatment . Industry analysis & Market Report on Dermatophytosis Treatment is a syndicated market report, published as Global Dermatophytosis Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dermatophytosis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
